Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Gene Technology FY16 Revenues Up 15 Percent

NEW YORK (GenomeWeb) – Oxford Gene Technology today reported a 15 percent increase in revenues for fiscal year 2016 on strong growth in product sales.

For the 12-month period ended Sept. 30, OGT's revenues increased to £19.7 million ($24.5 million) from £17.1 million in FY 2015, as product sales climbed 29 percent to £18.4 million from £14.3 million on increased demand for the company's Cytocell fluorescence in situ hybridisation probes and CytoSure molecular arrays.
 
The UK-based firm said that Cytocell saw double-digit growth, outpacing growth in the overall market for FISH probes, while the customer base for CytoSure saw a “large increase.” Sales of the SureSeq next-generation sequencing library preparation products also increased, reflecting OGT’s investment in new product development, it said.
 
"The strategic decisions we have made over the last few years have reshaped the company to create a streamlined and profitable business that is fully focused on the development of innovative products for molecular genetics," OGT CEO Mike Evans said in a statement. "Focusing on our integrated portfolio of molecular genetics products has driven strong sales growth and a significant increase in profits from commercial activities."
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.